• Email page
14 January 2015
Merrion Pharmaceuticals plc Announces Completion of Disposal of
Citywest Facility

Dublin, Ireland - 14 January 2015: Merrion Pharmaceuticals plc ("Merrion" or the "Company") today announces that further to its announcement of 17 December 2014 regarding the disposal of its Citywest Facility, that the sale has now successfully closed.

About Merrion Pharmaceuticals plc

Merrion Pharmaceuticals plc (www.merrionpharma.com) is a publicly listed (ESM:MERR) pharmaceutical company focused on delivering innovation to the market by partnering with complementary companies to develop patented products. Established in 2003, Merrion Pharmaceuticals is primarily engaged in facilitating the development of oral forms (tablets/capsules) of drugs that have suboptimal absorption, many of which can only be given by injection, through the use of Merrion Pharmaceutical's proprietary drug delivery technology platform.

Investor Enquiries:
Merrion Pharmaceuticals plc.
John Fox
T +353 1 642 3300
www.merrionpharma.com
Media Enquiries:
Dempsey Corporate
Conor Dempsey
T +353 (0)86 247 9892
Email:conor.dempsey@dempseycorporate.com
Davy Corporate Finance
Anthony Farrell / Barry Murphy
T +353 1 679 6363


distributed by